Definitive Contract HHSD200201690099C
Award Date
7/1/16
Potential Completion Date
6/30/17
Potential Value
$51M
Federal Agency
CDC Pittsburgh
Awardee
Glaxosmithkline, LLC
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
5
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $62,089,503.55 firm fixed price contract to Glaxosmithkline, LLC to provide vaccines for adults. The contract, which has no set-aside designation, runs from July 1, 2015 to June 30, 2016 and is for the company's pharmaceutical products and vaccine services. Glaxosmithkline, a foreign-owned for-profit organization, has provided a range of vaccines and antiviral medications to various federal agencies through both contracts and...
This is a $69,857,670.45 firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, doing business as Glaxosmithkline, for 2016 pandemic influenza preparedness efforts. The contract has a completion date of February 28, 2017 and was awarded on December 18, 2015. There was no set-aside designation used. Glaxosmithkline is a pharmaceutical company that provides vaccines, antiviral medications, and other products to various federal agencies,...
This is a $282,489.95 firm fixed price delivery order awarded by the Department of Health and Human Services Office of the Assistant Secretary for Administration to Glaxosmithkline, LLC, a foreign-owned pharmaceutical company. The contract is for the provision of pharmaceutical products, including influenza virus and hepatitis vaccines, COVID-19 treatments, vaccine adjuvants, and antiviral medications, to support disease prevention efforts, immunization programs, drug stockpiling initiatives,...
This federal contract award, valued at $102,189,000.00, was issued by the Centers for Disease Control and Prevention (CDC) to Glaxosmithkline, LLC, a pharmaceutical company, to provide adult influenza vaccines. The contract is a definitive, firm fixed-price contract without any set-aside designation. Glaxosmithkline has provided a range of pharmaceutical goods and services to various U.S. government agencies, including vaccines, antiviral medications, and COVID-19 treatments. The company also...
This is a federal contract award by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to GlaxoSmithKline, LLC, a pharmaceutical company, for the delivery of influenza vaccines. The contract is a Delivery Order issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), with a Firm Fixed Price pricing type and a potential value of $1,319,230.00. There was no set-aside designation used for this award. GlaxoSmithKline has provided a...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to GlaxoSmithKline, LLC on December 23, 2016 for the 2017 adult flu season. The firm fixed price contract has a ceiling value of $12,408,000.00 and a performance period ending February 28, 2018. The contract does not have a set-aside designation. GlaxoSmithKline, a pharmaceutical company, has provided a range of products to U.S. government agencies through federal contracts, including influenza...
This federal contract award is for vaccines and pharmaceutical products provided to the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Administration by GlaxoSmithKline, LLC. The contract has a potential value of $115,680.30, is a firm fixed price delivery order, and is not set aside for any specific business type. The contract was awarded on September 12, 2017, with a completion date of September 22, 2017. GlaxoSmithKline, a large pharmaceutical company, has...
The U.S. government awarded a $171,258 firm fixed price delivery order contract to Glaxosmithkline, LLC for the provision of vaccines. The contract was awarded by the Office of the Assistant Secretary for Administration, a civilian federal agency, and was issued under Glaxosmithkline's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. The contract has a period of performance ending on January 31, 2020 and does not have a set-aside designation. Glaxosmithkline has provided a...
This federal contract was awarded by the U.S. Department of Health and Human Services (HHS) to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antivirals, and other pharmaceutical products to government agencies. The $121,881.06 delivery order contract is for Glaxo vaccines, issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract vehicle. The contract has a firm fixed price pricing type and was not set aside for any small business...
This is a federal contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Administration to Glaxosmithkline, LLC, a pharmaceutical company, for the delivery of vaccines. The contract has a potential value of $151,681.81 and is a delivery order under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule contract with the General Services Administration. The contract is for a firm fixed price and does not have a set-aside designation. The...